Overview
Veana Therapeutics is dedicated to developing innovative, safe, cancer fighting medicines
Veana’s VIMO technology is based on orally bioavailable anti-cancer agents that selectively attack and destroy the energy powerhouses (mitochondria) of cancer cells in a fashion that subsequently stimulates the immune system.
Veana’s VIMO platform of α-TEA salt form-based products can be combined with other forms of immunotherapy to further improve anti-tumor activity.